SMTL ID : 2qi7.1

Crystal structure of protease inhibitor, MIT-2-AD86 in complex with wild type HIV-1 protease

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.85 Å

Oligo State

homo-dimer

Ligands

2 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.1: 3 residues within 4Å: Chain A: R.14, G.16, G.17 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:G.17 Water bridges: A:G.16, A:P.63 Salt bridges: A:R.14 PO4.5: 1 residues within 4Å: Chain B: P.1 No protein-ligand interaction detected (PLIP)

3 x ACT: ACETATE ION(Non-functional Binders)

ACT.2: 3 residues within 4Å: Chain A: K.20, E.21, N.83 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:K.20 Hydrogen bonds: A:E.21 ACT.3: 2 residues within 4Å: Chain A: Q.58, D.60 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:Q.58 ACT.4: 2 residues within 4Å: Chain A: M.36, N.37 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:M.36 Hydrogen bonds: A:N.37

1 x MZ9: N-[(1S,2R)-1-BENZYL-2-HYDROXY-3-{[(4-METHOXYPHENYL)SULFONYL][(2S)-2-METHYLBUTYL]AMINO}PROPYL]-4-OXOHEXANAMIDE(Non-covalent)

MZ9.6: 24 residues within 4Å: Chain A: D.25, G.27, A.28, D.29, G.48, G.49, I.50, P.81, V.82 Chain B: R.8, L.23, D.25, G.27, A.28, D.29, D.30, V.32, I.47, G.48, G.49, I.50, P.81, V.82, I.84 19 PLIP interactions: 9 interactions with chain A, 10 interactions with chain B Hydrophobic interactions: A:A.28, A:P.81, A:V.82, B:L.23, B:A.28, B:V.32, B:P.81, B:V.82, B:I.84 Hydrogen bonds: A:G.27, A:G.27, A:G.27, A:D.29, B:D.29, B:D.30 Water bridges: A:I.50, B:I.50 Salt bridges: A:D.25, B:D.25

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Altman, M.D. et al., HIV-1 protease inhibitors from inverse design in the substrate envelope exhibit subnanomolar binding to drug-resistant variants. J.Am.Chem.Soc. (2008)

Release Date

2008-04-22

Peptides

Protease: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Protease

Related Entries With Identical Sequence